Skip to main content
Signal8
Launch Terminal
Oh Chad profile photo

Chad Oh

CIK: 0001882166

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AEON Biopharma, Inc. logo
AEON

AEON Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Mar 4, 2026
    Award(A)
    Direct
    1.3M shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Feb 17, 2026
    Award(A)
    Direct
    862.5K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 21, 2025
    Award(A)

    Restricted Stock Units

    Direct
    1.3M shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Aug 31, 2024
    Award(A)
    Direct
    192.1K shares-

1-4 of 4

About Oh Chad

Oh Chad (SEC CIK 0001882166) files insider reports with the SEC as CHIEF MEDICAL OFFICER of AEON Biopharma, Inc. (AEON).

Signal8 holds 3 ownership filings by Oh Chad, all Form 4s, filed between Sep 4, 2024 and Mar 11, 2026. Those filings report 4 transactions, from Aug 31, 2024 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Oh Chad's filings is in IRVINE, CA.

Recent filings by Oh Chad

  • Mar 4, 2026: Grant or award of AEON shares (Form 4, code A).
  • Feb 17, 2026: Grant or award of AEON shares (Form 4, code A).
  • May 21, 2025: Grant or award of AEON derivative securities (Form 4, code A).
  • Aug 31, 2024: Grant or award of AEON shares (Form 4, code A).

Other insiders filing for AEON Biopharma, Inc. (AEON)

How to read Form 4 transaction codes